tiprankstipranks
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
US Market
SNSE
Sensei Biotherapeutics
RESEARCH TOOLSreports

Sensei Biotherapeutics (SNSE) Financial Statements

Compare
234 Followers

Sensei Biotherapeutics Financial Overview

Sensei Biotherapeutics's market cap is currently $33.90M. The company's EPS TTM is $; its P/E ratio is -0.65; Sensei Biotherapeutics is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -551.00K$ -571.00K$ -1.81M$ -685.00K$ -209.00K
Operating Income$ -31.66M$ -37.06M$ -49.12M$ -37.48M$ -19.45M
EBITDA$ -29.52M$ -33.39M$ -46.56M$ -35.44M$ -18.20M
Net Income$ -30.16M$ -34.10M$ -48.59M$ -36.79M$ -20.10M
Balance Sheet
Cash & Short-Term Investments$ 41.34M$ 65.76M$ 107.12M$ 147.62M$ 16.60M
Total Assets$ 45.36M$ 74.37M$ 118.38M$ 153.22M$ 21.43M
Total Debt$ 3.85M$ 6.21M$ 8.03M$ 2.35M$ 685.00K
Net Debt$ -6.15M$ -6.80M$ -9.76M$ -4.80M$ -15.91M
Total Liabilities$ 6.97M$ 9.48M$ 14.97M$ 6.71M$ 5.54M
Stockholders' Equity$ 38.39M$ 64.89M$ 103.41M$ 146.51M$ 15.89M
Cash Flow
Free Cash Flow$ -24.82M$ -32.20M$ -39.35M$ -32.28M$ -18.91M
Operating Cash Flow$ -24.67M$ -32.02M$ -39.03M$ -30.26M$ -17.70M
Investing Cash Flow$ 22.44M$ 38.41M$ 49.95M$ -143.12M$ -1.40M
Financing Cash Flow$ -787.00K$ -11.17M$ -287.00K$ 163.94M$ 35.45M
Currency in USD

Sensei Biotherapeutics Earnings and Revenue History

Income Statement >

Sensei Biotherapeutics Debt to Assets

Balance Sheet >

Sensei Biotherapeutics Cash Flow

Cash Flow >

Sensei Biotherapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >